By Chris Moss | Published 8 March 2019
Becky Furuta was on cloud
nine. Not only did she have a healthy, happy two-year-old, but the
promising pro-cyclist was now pregnant with her second child, and so
far everything had gone smoothly. Although she was tired and hadn’t
gained much weight, she put this down to the day-to-day stresses of
life as a working mum.
But one afternoon, everything changed. Heading out for her regular training ride, she soon realised something was seriously wrong.
“I was feeling OK at the start, but by the middle of the ride I felt like I couldn’t move my legs – I was physically exhausted.” Becky recalls. “I went home, filled up a bottle of water, drank it, filled up a second bottle and drank that, and I was filling up the third bottle when I looked at my husband and said: ‘I’m pretty sure I have diabetes’.”
After being diagnosed with type 1 diabetes at the age of 28, Becky’s promising cycling career seemed to be over. But she defied her doctor’s advice to make a return to the saddle, joining Team Novo Nordisk - the world’s first all-diabetes pro-cycling team – and their mission to inspire, empower and educate others affected by diabetes.
In a new podcast to mark International Women’s Day, Becky reflects on her life on and off the bike, and explains how determination and self-discipline help her strike the perfect balance between work, motherhood and managing type 1 diabetes.
“Women often put themselves last, but sometimes putting yourself first can be the greatest gift to your family,” she says.
Listen to the podcast above to hear Becky’s remarkable story, and learn more about her work with Team Novo Nordisk on teamnovonordisk.com.
Katja Iversen, CEO of Women Deliver, works every day to drive progress in girls’ and women’s health and rights. We caught up with Katja in between travels to discuss progress, threats and the power of young people.
Lotte Bjerre Knudsen, Scientific Vice President at Novo Nordisk, discovered the molecule liraglutide and oversaw its journey from “underdog candidate” to a treatment for more than a million people with diabetes and obesity.
Explore features and points of view from Novo Nordisk
and the society we serve.
Discovering next generation of insulins
We continuously turn science and technologies into the next generation of efficacious and safe biological medicines.
Do you want to know more about living with type 1 diabetes?
What is type 1 diabetes? How is it diagnosed? How is it treated?
Understanding type 1 diabetes